ATE212548T1 - Behandlung und prophylaxe von pankreatitis - Google Patents

Behandlung und prophylaxe von pankreatitis

Info

Publication number: ATE212548T1
Authority: AT; Austria
Prior art keywords: pancreatitis; treatment; prophylaxis; troglitazone; prevention
Prior art date: 1996-03-18

Application number

AT97301773T

Other languages

English (en)

Inventor

Toshihiko Fujiwara

Hiroyoshi Horikoshi

Chome

Masaharu Fukami

Original Assignee

Sankyo Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-03-18

Filing date

1997-03-17

Publication date

2002-02-15

1997-03-17 Application filed by Sankyo Co filed Critical Sankyo Co

2002-02-15 Application granted granted Critical

2002-02-15 Publication of ATE212548T1 publication Critical patent/ATE212548T1/de

Links

206010033645 Pancreatitis Diseases 0.000 title abstract 2
238000011282 treatment Methods 0.000 title abstract 2
238000011321 prophylaxis Methods 0.000 title 1
229940122355 Insulin sensitizer Drugs 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
150000001467 thiazolidinediones Chemical class 0.000 abstract 1
-1 troglitazone Chemical class 0.000 abstract 1
GXPHKUHSUJUWKP-UHFFFAOYSA-N troglitazone Chemical compound C1CC=2C(C)=C(O)C(C)=C(C)C=2OC1(C)COC(C=C1)=CC=C1CC1SC(=O)NC1=O GXPHKUHSUJUWKP-UHFFFAOYSA-N 0.000 abstract 1
229960001641 troglitazone Drugs 0.000 abstract 1
GXPHKUHSUJUWKP-NTKDMRAZSA-N troglitazone Natural products C([C@@]1(OC=2C(C)=C(C(=C(C)C=2CC1)O)C)C)OC(C=C1)=CC=C1C[C@H]1SC(=O)NC1=O GXPHKUHSUJUWKP-NTKDMRAZSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Thiazole And Isothizaole Compounds (AREA)
Superconductors And Manufacturing Methods Therefor (AREA)
Catching Or Destruction (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

AT97301773T 1996-03-18 1997-03-17 Behandlung und prophylaxe von pankreatitis ATE212548T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP6106396		1996-03-18
JP25020196		1996-09-20

Publications (1)

Publication Number	Publication Date
ATE212548T1 true ATE212548T1 (de)	2002-02-15

Family

ID=26402115

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97301773T ATE212548T1 (de)	1996-03-18	1997-03-17	Behandlung und prophylaxe von pankreatitis

Country Status (18)

Country	Link
US (1)	US5753681A (de)
EP (1)	EP0796618B1 (de)
KR (1)	KR100542778B1 (de)
CN (1)	CN1178657C (de)
AT (1)	ATE212548T1 (de)
AU (1)	AU708315B2 (de)
CA (1)	CA2200126C (de)
CZ (1)	CZ283968B6 (de)
DE (1)	DE69710111T2 (de)
DK (1)	DK0796618T3 (de)
ES (1)	ES2167678T3 (de)
HU (1)	HUP9700598A3 (de)
ID (1)	ID16266A (de)
IL (1)	IL120443A (de)
NO (1)	NO313179B1 (de)
NZ (1)	NZ314406A (de)
PT (1)	PT796618E (de)
TW (1)	TW548102B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9711683D0 (en) *	1997-06-05	1997-08-06	Smithkline Beecham Plc	Composition
TW475931B (en) *	1997-10-08	2002-02-11	Sankyo Co	A substituted condensed heterocyclic compound
CN1235887C (zh)	1998-03-30	2006-01-11	日本烟草产业株式会社	噁唑基乙醇衍生物的制备方法
US7045519B2 (en) *	1998-06-19	2006-05-16	Chiron Corporation	Inhibitors of glycogen synthase kinase 3
WO1999065897A1 (en)	1998-06-19	1999-12-23	Chiron Corporation	Inhibitors of glycogen synthase kinase 3
AP2001002036A0 (en) *	1998-07-21	2001-03-31	Smithkline Beecham Plc	Use of glucose uptake enhancer for reducing apoptosis.
US20040102486A1 (en) *	1998-11-12	2004-05-27	Smithkline Beecham Corporation	Novel method of treatment
US20030153607A1 (en) *	1998-11-12	2003-08-14	Smithkline Beecham P.L.C.	Novel composition and use
WO2001000223A2 (en) *	1999-06-25	2001-01-04	Minimed Inc.	Multiple agent diabetes therapy
CN1155586C (zh)	1999-08-23	2004-06-30	杏林制药株式会社	取代的苄基噻唑烷-2,4-二酮衍生物
KR100700304B1 (ko)	1999-08-23	2007-03-29	교린 세이야꾸 가부시키 가이샤	치환된 벤질티아졸리딘-2,4-디온 유도체
US6452014B1 (en) *	2000-12-22	2002-09-17	Geron Corporation	Telomerase inhibitors and methods of their use
WO2002067969A2 (en)	2001-02-21	2002-09-06	Medtronic Minimed, Inc.	Stabilized insulin formulations
US6737401B2 (en)	2001-06-28	2004-05-18	Metronic Minimed, Inc.	Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom
MA33248B1 (fr)	2009-04-01	2012-05-02	Genentech Inc	Traitement de troubles résistant à l'insuline

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5522636A (en) *	1978-08-04	1980-02-18	Takeda Chem Ind Ltd	Thiazoliding derivative
JPS6051189A (ja) *	1983-08-30	1985-03-22	Sankyo Co Ltd	チアゾリジン誘導体およびその製造法
DE3343141A1 (de) *	1983-11-29	1985-06-05	Hermann P.T. 7400 Tübingen Ammon	Verwendung von cystein-derivaten oder deren salzen, zur steigerung der insulinsekretion der langerhans'schen inseln der bauchspeicheldruese
CN1003445B (zh) *	1984-10-03	1989-03-01	武田药品工业株式会社	噻唑烷二酮衍生物，其制备方法和用途
AR240698A1 (es) *	1985-01-19	1990-09-28	Takeda Chemical Industries Ltd	Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
HU210339B (en) *	1985-05-21	1995-03-28	Pfizer	Process for preparing thiazolidinediones and their pharmaceutical compositions haring hypoglycemic effect
US5232925A (en) *	1987-09-04	1993-08-03	Beecham Group P.L.C.	Compounds
US5194443A (en) *	1987-09-04	1993-03-16	Beecham Group P.L.C.	Compounds
US5260445A (en) *	1987-09-04	1993-11-09	Beecham Group P.L.C.	2,4-thiazolidinediones
EP0842925A1 (de) *	1987-09-04	1998-05-20	Beecham Group Plc	Substituierte Thiazolidindionderivate
MX15171A (es) *	1988-03-08	1993-05-01	Pfizer	Derivados de tiazolidinodiona hipoglicemicos
ZA895838B (en) *	1988-08-18	1991-03-27	Syntex Inc	Pharmaceutical compounds
JP2845743B2 (ja) *	1992-12-28	1999-01-13	三菱化学株式会社	新規なナフタレン誘導体
WO1995002340A1 (en) *	1993-07-13	1995-01-26	Moizis Janica M	Fastener for clothing
US5728720A (en) *	1993-12-27	1998-03-17	Japan Tobacco Inc.	Isoxazolidinedione compounds and use thereof
CZ289317B6 (cs) *	1994-04-11	2002-01-16	Sankyo Company Limited	Heterocyklická sloučenina, farmaceutický prostředek ji obsahující a její pouľití
US5594015A (en) *	1994-06-22	1997-01-14	Regents Of The University Of California	Thiazolidine derivatives for the treatment of psoriasis
FR2721608B1 (fr) *	1994-06-22	1996-07-19	Rhone Poulenc Rorer Sa	Dérivés de thiazolidine, leur préparation et les médicaments les contenant.
CZ261095A3 (en) *	1994-10-07	1996-04-17	Sankyo Co	Oxime derivatives, process of their preparation, pharmaceutical composition containing thereof and their use
IL118474A (en) *	1995-06-01	2001-08-08	Sankyo Co	Benzimideol derivatives and pharmaceutical preparations containing them

1997
- 1997-03-13 IL IL12044397A patent/IL120443A/xx not_active IP Right Cessation
- 1997-03-13 NZ NZ314406A patent/NZ314406A/xx unknown
- 1997-03-14 CZ CZ97790A patent/CZ283968B6/cs unknown
- 1997-03-14 ID IDP970826A patent/ID16266A/id unknown
- 1997-03-17 HU HU9700598A patent/HUP9700598A3/hu unknown
- 1997-03-17 DE DE69710111T patent/DE69710111T2/de not_active Expired - Fee Related
- 1997-03-17 CA CA002200126A patent/CA2200126C/en not_active Expired - Fee Related
- 1997-03-17 AU AU16285/97A patent/AU708315B2/en not_active Ceased
- 1997-03-17 EP EP97301773A patent/EP0796618B1/de not_active Expired - Lifetime
- 1997-03-17 NO NO19971219A patent/NO313179B1/no unknown
- 1997-03-17 ES ES97301773T patent/ES2167678T3/es not_active Expired - Lifetime
- 1997-03-17 AT AT97301773T patent/ATE212548T1/de not_active IP Right Cessation
- 1997-03-17 TW TW086103285A patent/TW548102B/zh not_active IP Right Cessation
- 1997-03-17 DK DK97301773T patent/DK0796618T3/da active
- 1997-03-17 PT PT97301773T patent/PT796618E/pt unknown
- 1997-03-17 US US08/819,686 patent/US5753681A/en not_active Expired - Fee Related
- 1997-03-18 KR KR1019970009207A patent/KR100542778B1/ko not_active Expired - Fee Related
- 1997-03-18 CN CNB971112118A patent/CN1178657C/zh not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE69710111D1 (de)	2002-03-14
NO971219D0 (no)	1997-03-17
PT796618E (pt)	2002-06-28
IL120443A (en)	2000-07-16
CA2200126A1 (en)	1997-09-18
KR19980023975A (ko)	1998-07-06
HUP9700598A3 (en)	1998-10-28
EP0796618B1 (de)	2002-01-30
CN1170575A (zh)	1998-01-21
IL120443A0 (en)	1997-07-13
ID16266A (id)	1997-09-18
US5753681A (en)	1998-05-19
AU708315B2 (en)	1999-07-29
HK1003051A1 (en)	1998-10-09
KR100542778B1 (ko)	2006-04-14
NZ314406A (en)	2000-12-22
MX9702058A (es)	1998-03-31
CA2200126C (en)	2006-08-15
CZ283968B6 (cs)	1998-07-15
CZ79097A3 (en)	1997-10-15
EP0796618A1 (de)	1997-09-24
HU9700598D0 (en)	1997-05-28
DE69710111T2 (de)	2002-10-02
NO971219L (no)	1997-09-19
ES2167678T3 (es)	2002-05-16
TW548102B (en)	2003-08-21
AU1628597A (en)	1997-09-25
CN1178657C (zh)	2004-12-08
DK0796618T3 (da)	2002-05-06
HUP9700598A2 (hu)	1998-09-28
NO313179B1 (no)	2002-08-26

Legal Events

Date	Code	Title	Description
2002-07-15	UEP	Publication of translation of european patent specification
2009-12-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE212548T1 (de)	2002-02-15	Behandlung und prophylaxe von pankreatitis
ATE425750T1 (de)	2009-04-15	Verwendung von triglyceriden mit mittellangen ketten zur behandlung und vorbeugung der alzheimerschen erkrankung
PL304649A1 (en)	1995-02-20	Novel derivatives of taxane and pharmaceutical agents
DE69431056D1 (de)	2002-08-29	Substituierte oxazolyl-derivate zur behandlung von entzündungen
LU91271I2 (fr)	2006-10-02	Natalizumab et ses dérivés pharmaceutiquement acceptables (TYSABRI)
ATE215530T1 (de)	2002-04-15	7-substituierte-8-substituierte-9-substituierte amino-7-demethyl-6-deoxy-tetracycline als antibiotische mittel
ATE253063T1 (de)	2003-11-15	5-ht1f-agonisten
FI890311A0 (fi)	1989-01-20	Kemiska foereningar.
ATE224714T1 (de)	2002-10-15	Behandlung von tinnitus mit neuroprotektiven wirkstoffen
DE58905201D1 (de)	1993-09-16	Mittel zur behandlung des parkinson-syndroms.
DE69825605D1 (de)	2004-09-16	Behandlung der schizophrenie und der psychose
ID25478A (id)	2000-10-05	Agonis 5-ht1f
DK0604186T3 (da)	1997-06-16	HIV-proteaseinhibitorer, som er egnede til behandling af AIDS
DE69827387D1 (de)	2004-12-09	Verwendung von pramipexol zur behandlung von restless-legs-syndrom
MX9304626A (es)	1994-02-28	Derivados heterociclicos utiles en el tratamiento de enfermedades cardiovasculares.
NO943765L (no)	1995-04-10	Aryloksybenzen-herbicidmidler
ATE222255T1 (de)	2002-08-15	14-substituierte marcfortine und derivate als antiparasitäre mittel
DE69824670D1 (de)	2004-07-29	TCF-II für Vorbeugung und/oder Behandlung von strahlungsinduzierter Störungen
PT971714E (pt)	2002-12-31	Metodo utilizando inibidores ciclooxigenase-2 no tratamento e prevencao da demencia
ATE292970T1 (de)	2005-04-15	Topische zusammensetzung enthaltend brucin und ihre verwendung zur behandlung von hautschäden
ATE262527T1 (de)	2004-04-15	Zur vorbeugung oder behandlung von östrogenabhängigen krankheiten nützliche pyrrolo(2.1.5-cd)indolizin-derivate